| Literature DB >> 26951114 |
Nancy Lévesque1, Daniel Leclerc1, Tenzin Gayden2, Anthoula Lazaris3, Nicolas De Jay2, Stephanie Petrillo3, Peter Metrakos3, Nada Jabado2, Rima Rozen4.
Abstract
Polymorphisms and decreased activity of methylenetetrahydrofolate reductase (MTHFR) are linked to disease, including cancer. However, epigenetic regulation has not been thoroughly studied. Our goal was to generate DNA methylation profiles of murine/human MTHFR gene regions and examine methylation in brain and liver tumors. Pyrosequencing in four murine tissues revealed minimal DNA methylation in the CpG island. Higher methylation was seen in liver or intestine in the CpG island shore 5' to the upstream translational start site or in another region 3' to the downstream start site. In the latter region, there was negative correlation between expression and methylation. Three orthologous regions were investigated in human MTHFR, as well as a fourth region between the two translation start sites. We found significantly increased methylation in three regions (not the CpG island) in pediatric astrocytomas compared with control brain, with decreased expression in tumors. Methylation in hepatic carcinomas was also increased in the three regions compared with normal liver, but the difference was significant for only one CpG. This work, the first overview of the Mthfr/MTHFR epigenetic landscape, suggests regulation through methylation in some regions, demonstrates increased methylation/decreased expression in pediatric astrocytomas, and should serve as a resource for future epigenetic studies.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26951114 DOI: 10.1007/s00335-016-9624-0
Source DB: PubMed Journal: Mamm Genome ISSN: 0938-8990 Impact factor: 2.957